buying digital currency, Top

American enterprises filed a 337 investigation application for specific urine splash-proof devices and their components. According to the Ministry of Commerce, on December 5, For Kids By Parents,Inc of the United States filed an application with the United States International Trade Commission in accordance with Section 337 of the United States Tariff Act of 1930. Accused that certain urine splash guards and components there exported to, imported from or sold in the United States infringed its patent right, requested to initiate 337 investigation, and issued general exclusion order, limited exclusion order and prohibition order. Ten enterprises in China were involved in the case.Hong Kong stocks rose by 87% on the first day of listing in Mao Geping, with a turnover of nearly HK$ 1.9 billion.Topcon is reported to have received an offer from KKR and EQT.

Huawei Terminal:: The world's first star-flashing gateway route Q7, the parent route of Huawei Xiaozi Ling, was officially put on sale at 10:08 today, with a price of 1999 yuan.Ultra-long-term Treasury ETF rose sharply at the opening, with "Boshi SSE 30-year Treasury ETF" rising by 0.65% and "Pengyang China Bond -30-year Treasury ETF" rising by 0.65%.The decline of FTSE China A50 index futures quickly expanded to 1%.

Hong Kong auto stocks opened higher, with Weilai Auto (09866.HK) up 6.7%, Xpeng Motors (09868.HK) up 6.2% and LI (02015.HK) up 3.4%.The two departments issued a document: improve the working mechanism of centralized procurement and implementation of medicines. Recently, the National Medical Insurance Bureau and the National Health and Health Commission issued the Notice on Improving the Working Mechanism of Centralized Procurement and Implementation of Medicines. On the basis of the original policy, the Notice further improves the centralized procurement and implementation mechanism of medicines, guides medical institutions and pharmaceutical enterprises to follow and support the centralized procurement mechanism, and consolidates and deepens the reform results of centralized procurement of medicines and medical consumables, so that more patients can benefit. The "Notice" focuses on the detailed measures from the aspects of admission, use, monitoring, assessment and feedback of centralized drug consumables, which reflects the policy orientation of coordinated supervision between departments and preferential use of selected products. (CCTV News)NVIDIA responded to the investigation: I am happy to answer any questions from the regulators. Today, regarding the investigation by the regulators, NVIDIA responded to Sina Technology and said: "Nvidia won by strength, which is reflected in our benchmark test results and value to customers, and customers can choose any solution that suits them best. We strive to provide the best products in every region and fulfill our promises wherever we do business. We are happy to answer any questions that regulators have about our business. " (Sina Technology)